VYNE Therapeutics Inc. Quarterly Interest Expense in USD from Q1 2020 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: VYNE Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q4 2022.
VYNE Therapeutics Inc. Interest Expense for the quarter ending December 31, 2022 was $0.000.
VYNE Therapeutics Inc. Interest Expense for the twelve months ending December 31, 2022 was $0.000, a 100% decline year-over-year.
VYNE Therapeutics Inc. annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
VYNE Therapeutics Inc. annual Interest Expense for 2021 was $5.61M, a 27.8% increase from 2020.
VYNE Therapeutics Inc. annual Interest Expense for 2020 was $4.39M, a 377% increase from 2019.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2022	$0	$0	$0		Oct 1, 2022	Dec 31, 2022	10-K	2023-03-14
Q3 2022	$0	$0	-$3.47M	-100%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$3.47M	$0	-$1.07M	-100%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$4.55M	$0	-$1.06M	-100%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$5.61M	$0	-$1.16M	-100%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$6.77M	$3.47M	+$2.38M	+218%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$4.39M	$1.07M	+$4K	+0.37%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-12
Q1 2021	$4.39M	$1.06M	-$5K	-0.47%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$4.39M	$1.16M			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-17
Q3 2020		$1.09M			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$1.07M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020		$1.07M			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.